41
Participants
Start Date
January 28, 2019
Primary Completion Date
September 28, 2023
Study Completion Date
September 28, 2023
Crizotinib
receive crizotinib orally
Beijing Cancer Hospital, Internal Department, Beijing
Jilin Province Cancer Hospital, Changchun
Jilin Provincial Cancer Hospital, Changchun
Shanghai Chest Hospital, Shanghai
Zhongshan Hospital Fudan University, Shanghai
Eastern Theater General Hospital ,QinHuai District Medical Area, Nanjing
Department of Respiratory, The First Affiliated Hospital of College of Medicine, Zhejiang University, Hangzhou
The First Affiliated Hospital of College of Medicine, Zhejiang University, Hangzhou
Fujian Province Oncology Hospital, Fuzhou
The First Affiliated Hospital of Guangzhou Medical University, Guangzhou
The First Affiliated Hospital of Guangzhou Medical University, Liwan District,Guangzhou
Sichuan Province Cancer Hospital/Department of Pulmonary Tumor, Chengdu
Sichuan Province Cancer Hospital, Chengdu
West China Hospital of Sichuan University, Chengdu
Lead Sponsor
Pfizer
INDUSTRY